I think if we depend on people to Be Good when there are big financial incentives not to, we're already screwed. We have to look at why the incentives are bad.

I think if we depend on people to Be Good when there are big financial incentives not to, we're already screwed. We have to look at why the incentives are bad. > With the price now high, other companies could conceivably make generic copies, since patents have long expired. One factor that could discourage that option is that Daraprim’s distribution is now tightly controlled, making it harder for generic companies to get the samples they need for the required testing. This should've been the second paragraph of the article, not buried near the bottom. The author seems to be expecting a system to make legal monopolies behave nicely. Instead we should stop creating legal monopolies.